SCARB1 and neoplasm: Using this approach, it could be demonstrated that 92R mAb, and its humanized version (Srb1), both induce a strong specific inhibition of tumor growth in vivo, increasing survival of the xenotransplanted animals around 2.6-fold, as compared to isotype control mAb treated animals.